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We used the Mendelian randomization design to explore
the potential causal association of smoking with ischemic
stroke and intracerebral hemorrhage using summary statis-
tics data for 34,217 ischemic stroke cases and 404,630
noncases, and 1,545 cases of intracerebral hemorrhage and
1,481 noncases. Genetic predisposition to smoking initia-
tion (ever smoking regularly), based on up to 372 single-
nucleotide polymorphisms, was statistically signiﬁcantly
positively associated with any ischemic stroke, large artery
stroke, and small vessel stroke but not cardioembolic stroke
or intracerebral hemorrhage. This study provides genetic
support for a causal association of smoking with ischemic
stroke, particularly large artery and small vessel stroke.
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Evidence from observational studies indicates that smokingincreases the risk of stroke.1 Even smoking as little as 1 cig-
arette per day is associated with an approximately 25% to 30%
increased risk of stroke.1 However, the role of smoking for
ischemic stroke subtypes and intracerebral hemorrhage is
unclear. Moreover, because data on smoking in relation to
stroke originate from observational studies, which are vulnera-
ble to confounding, the causal nature of the association
between smoking and stroke risk remains elusive.We therefore
implemented the Mendelian randomization (MR) design to
assess the association of genetic predisposition to smoking with
ischemic stroke and its main subtypes as well as intracerebral
hemorrhage. MR is a method that can be used to strengthen
causal inference in observational studies by utilizing genetic
variants associated with the exposure as instrumental variables
for the exposure.2
Subjects and Methods
Outcome Data
The current study is based on publicly available summary statistics
data for genetic associations with ischemic stroke and its subtypes from
the MEGASTROKE consortium, including data for 438,847
European-descent individuals (34,217 ischemic stroke cases and
404,630 noncases).3 The cases were subtyped according to the Trial
of Org 10172 in Acute Stroke Treatment criteria4 into large-artery
(n = 4,373), small vessel (n = 5,386), and cardioembolic (n = 7,193)
stroke. Summary statistics data for intracerebral hemorrhage were
available from a genome-wide association meta-analysis of 3,026
European-descent individuals (1,545 cases and 1,481 noncases).5 The
present MR study was approved by the Swedish Ethical Review
Authority.
Selection of Instrumental Variables
A genome-wide association meta-analysis of 1,232,091 individuals
identiﬁed 378 conditionally independent single-nucleotide poly-
morphisms (SNPs) at 259 loci (deﬁned as a 1Mb region surround-
ing the top p value) associated with ever smoking regularly
(hereafter referred to as smoking initiation) at genome-wide signiﬁ-
cance.6 Conditionally independent SNPs had been identiﬁed using
the novel, partial correlation-based score statistic method.7 The
378 SNPs explained 2.3% of the phenotypic variation in smoking
initiation. Thirteen and 113 SNPs were unavailable in the ischemic
stroke and intracerebral hemorrhage datasets, respectively. A proxy
SNP in linkage disequilibrium (R2 > 0.7) with the speciﬁed SNP was
identiﬁed for 7 and 61 of the missing SNPs for ischemic stroke and
intracerebral hemorrhage datasets, respectively. Thus, the smoking
initiation analyses included 372 SNPs in the analysis of ischemic
stroke and 326 SNPs in the analysis of intracerebral hemorrhage.
As an additional analysis, we used 126 SNPs associated with a
measure of lifetime smoking exposure that takes into account
smoking status and, among ever smokers, duration, heaviness, and
cessation.8 These SNPs were broadly distinct from the SNPs
predicting smoking initiation (only 9 SNPs overlapped) and strongly
associated with the positive control of lung cancer.8 All 126 SNPs
were available in the ischemic stroke dataset, whereas 109 SNPs
(including 41 proxy variants) were available for analysis of intracere-
bral hemorrhage. In a further secondary analysis, we used 53 condi-
tionally independent genome-wide signiﬁcant SNPs associated with
cigarettes smoked per day in a genome-wide association meta-
analysis of 337,334 ever smokers,6 which were available in the ische-
mic stroke dataset.
There was partial sample overlap between the 3 smoking pheno-
types. The genome-wide association studies of smoking initiation, life-
time smoking exposure, and cigarettes per day included, respectively,
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383,631 (of the total 1,232,091 individuals), 462,690, and
337,334 individuals from UK Biobank.
Statistical Analysis
Analyses were performed using the mrrobust9 and Mendelian-
Randomization10 packages. The principal analysis was conducted
using the inverse-variance weighted method, under a random-
effects model, and supplemented with the weighted median
approach.11 The MR-Pleiotropy RESidual Sum and Outlier and
MR-Egger regression methods were used to identify outliers and
pleiotropy.11,12 Smoking initiation is genetically correlated with
alcohol consumption (rg = 0.34) and education (rg = −0.40).6 In
a multivariable MR analysis, we included SNPs associated with
those exposures6,13 along with SNPs for smoking initiation. To
correct for multiple testing, we applied a Bonferroni-corrected
signiﬁcance threshold of α = 0.01 (where α = 0.05/5 outcomes).
Results
Genetic predisposition to smoking initiation was statistically
signiﬁcantly positively associated with any ischemic stroke,
large artery stroke, and small vessel stroke but not car-
dioembolic stroke or intracerebral hemorrhage in analyses
using the inverse-variance weighted method (Fig 1). Results
were similar in a sensitivity analysis based on the weighted
median method; the odds ratios per unit increase in log odds
of ever smoking regularly were 1.22 (95% conﬁdence inter-
val [CI] = 1.12–1.34, p = 7.6 × 10−6) for any ischemic
stroke, 1.59 (95% CI = 1.26–1.99, p = 6.7 × 10−5) for large
artery stroke, 1.35 (95% CI = 1.09–1.66, p = 0.005) for
small vessel stroke, 1.11 (95% CI = 0.94–1.32, p = 0.21) for
cardioembolic stroke, and 0.83 (95% CI = 0.50–1.37,
p = 0.47) for intracerebral hemorrhage. One outlier SNP
was identiﬁed in the analyses of any ischemic stroke but
none in the analyses of the other outcomes. Exclusion of the
outlier did not essentially change the results for smoking and
ischemic stroke (odds ratio = 1.23, 95% CI = 1.15–1.31,
p = 6.5 × 10−10). There was no indication of directional
pleiotropy (all p > 0.24). Restricting the analysis to 1 SNP in
each locus yielded similar results (odds ratio of ischemic
stroke = 1.23, 95% CI = 1.14–1.33, p = 7.0 × 10−8). The
association between genetic predisposition to smoking initia-
tion and ischemic stroke was weaker but remained statisti-
cally signiﬁcant in multivariable MR analysis that included
SNPs for alcohol consumption and education (odds
ratio = 1.14, 95% CI = 1.07–1.23, p = 1.8 × 10−4).
Findings were similar in analyses of lifetime smoking
exposure (Fig 2). Genetically predicted cigarettes smoked
per day was positively associated with ischemic stroke, but
the association was not statistically signiﬁcant in the inverse-
variance weighted analysis. The odds ratio was 1.14
(95% CI = 0.98–1.33, p = 0.09) per 1 standard deviation
(corresponding to about 8 cigarettes per day among current
smokers in the UK Biobank) increase in cigarettes per day.
Discussion
This study provides genetic support for a causal association
between smoking and increased risk of ischemic stroke, par-
ticularly large artery and small vessel stroke. We found no
causal association between smoking and cardioembolic stroke
or intracerebral hemorrhage.
Cigarette smoke can adversely affect the cardiovascular
system through its content of oxidant gases (eg, oxides of nitro-
gen and free radicals) and other toxic substances, which may
increase stroke risk through endothelial dysfunction, lipid
FIGURE 1: Associations of genetic predisposition to smoking initiation with ischemic stroke and its subtypes and intracerebral
hemorrhage. Odds ratios are expressed per unit increase in log odds of ever smoking regularly (smoking initiation). Estimates were
obtained using the inverse variance-weighted method under a random-effects model. CI = conﬁdence interval; OR = odds ratio.
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oxidation, inﬂammation, platelet activation, thrombogenesis,
and enhanced coagulability.14 Additionally, nicotine may
reduce cerebral blood ﬂow.14
Notable strengths of this MR study are that the analyses
were based on large sample sizes for ischemic stroke and a
robust genetic instrument for smoking initiation, comprising
372 SNPs. Thus, we had high statistical power to detect weak
associations with ischemic stroke. Nonetheless, the analyses of
intracerebral hemorrhage were based on a small sample size
and we cannot rule out that we may have overlooked a weak
association between smoking and intracerebral hemorrhage.
Population stratiﬁcation can affect the ﬁndings of MR studies
but we reduced this bias by using summary statistics data for
individuals of European ancestry only.
A possible criticism of the use of smoking initiation as a
phenotype is that it does not reﬂect exposure to cigarette
smoke. Therefore, in a complementary analysis we investi-
gated the association between a lifetime smoking index, which
takes into account smoking intensity, and found broadly simi-
lar results. In an additional secondary analysis, we observed a
suggestive, nonsigniﬁcant, dose-response association between
cigarettes smoked per day and ischemic stroke. However, that
analysis suffered from low precision due to low phenotypic
variation explained by the SNPs (about 1.1%–1.2%). More-
over, we were unable to stratify the analysis by smoking status
and could not examine nonlinear associations.
In conclusion, this MR study found support for
causal associations between smoking and increased risk of
ischemic stroke as a whole, large artery stroke, and small
vessel stroke, but not cardioembolic stroke and intracerebral
hemorrhage.
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